Palisade Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,734
Closed -$368K – 379
2023
Q3
$368K Hold
1,734
– – 0.01% 342
2023
Q2
$334K Hold
1,734
– – 0.01% 342
2023
Q1
$351K Sell
1,734
-51
-3% -$8.18K 0.01% 361
2022
Q4
$229K Sell
1,785
-215
-11% -$27.7K 0.01% 386
2022
Q3
$274K Hold
2,000
– – 0.01% 385
2022
Q2
$354K Hold
2,000
– – 0.01% 390
2022
Q1
$288K Hold
2,000
– – 0.01% 392
2021
Q4
$309K Hold
2,000
– – 0.01% 400
2021
Q3
$340K Hold
2,000
– – 0.01% 376
2021
Q2
$316K Hold
2,000
– – 0.01% 376
2021
Q1
$278K Hold
2,000
– – 0.01% 357
2020
Q4
$350K Buy
+2,000
New +$373K 0.01% 345
2020
Q3
– Sell
-2,000
Closed -$340K – 407
2020
Q2
$340K Hold
2,000
– – 0.01% 350
2020
Q1
$231K Hold
2,000
– – 0.01% 395
2019
Q4
$229K Buy
+2,000
New +$212K 0.01% 394

Other funds holding SGEN

Palisade Capital Management's SGEN Position: Q4 2023 in Review

Palisade Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,734 shares — an estimated $368K sold.

Palisade Capital Management first reported a position in SGEN in Q4 2019 and held it in 15 quarters. The position peaked at $368K in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Palisade Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Palisade Capital Management sold 1,734 Seagen Inc. Common Stock shares in Q4 2023, an estimated $368K.
  • Palisade Capital Management first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 15 quarters.
  • Palisade Capital Management's Seagen Inc. Common Stock position peaked at $368K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Palisade Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.